DGAT inhibitors (AstraZeneca)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameDGAT inhibitors (AstraZeneca)
Drug Alias Namediacylglycerol O-acyltransferase inhibitors (AstraZeneca)DGAT inhibitors (Zeneca)diacylglycerol acyltransferase inhibitors (AstraZeneca)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiacylglycerol O-acyltransferase inhibitors
TargetsDiacylglycerol O-acyltransferase
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZeneca Pharmaceuticals Group
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca PlcZeneca Pharmaceuticals Group
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A